NDC | 10956-599-12 |
Set ID | a0ccab02-5178-4e0d-9205-3567387ca3e5 |
Category | HUMAN OTC DRUG LABEL |
Packager | Reese Pharmaceutical Co |
Generic Name | |
Product Class | |
Product Number | |
Application Number |
- Active ingredient (in each tablet)
- Purpose
- Warnings
- Ask doctor before use if you have
- When using this product
- Stop use and ask doctor if
- If pregnant or breast feeding,
- Keep out of reach of children
- Use
- Inactive ingredients
- Directions
- PRINCIPAL DISPLAY PANEL
-
INGREDIENTS AND APPEARANCE
FAMILY WELLNESS MAXIMUM STRENGTH URINARY PAIN RELIEF
phenazopyridine hydrochloride tabletProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:10956-599 Route of Administration ORAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength PHENAZOPYRIDINE HYDROCHLORIDE (UNII: 0EWG668W17) (PHENAZOPYRIDINE - UNII:K2J09EMJ52) PHENAZOPYRIDINE HYDROCHLORIDE 97.5 mg Inactive Ingredients Ingredient Name Strength LACTOSE (UNII: J2B2A4N98G) MAGNESIUM SILICATE (UNII: 9B9691B2N9) Product Characteristics Color brown Score no score Shape ROUND Size 7mm Flavor Imprint Code P97 Contains Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:10956-599-12 1 in 1 CARTON 03/31/2017 1 12 in 1 BLISTER PACK; Type 0: Not a Combination Product Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date unapproved drug other 01/15/2015 Labeler - Reese Pharmaceutical Co (004172052) Registrant - Reese Pharmaceutical Co (004172052) Establishment Name Address ID/FEI Business Operations Reese Pharmaceutical Co 004172052 relabel(10956-599) , repack(10956-599)